Candel Therapeutics

CADL NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2023-12-31 2023-09-30 2023-06-30
Revenue $1,776 $0 $0
Gross Profit 1,464 -306 -295
EBITDA -10,006 -8,861 -8,878
EBIT -10,318 -9,106 -9,114
Net Income -11,095 -8,435 -9,614
Net Change In Cash 1,776 0 0
Free Cash Flow -7,469 -8,911 -7,364
Cash 35,413 42,983 51,894
Basic Shares 28,981 28,919 28,919

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $31 $125 $125 $125
Gross Profit -1,200 -862 125 125
EBITDA -37,191 -51,044 -35,839 -8,490
EBIT -38,391 -34,722 -36,071 -13,810
Net Income -37,939 -2,866 -36,124 -22,174
Net Change In Cash 31 125 125 125
Cost of Revenue 47,747
Free Cash Flow -34,701 -32,716 -24,053 -10,547
Cash 35,413 70,058 82,642 35,053
Basic Shares 28,935 28,823 28,689 29,148

Earnings Calls

Quarter EPS
2024-03-31 -$0.28
2023-12-31 -$0.38
2023-09-30 -$0.31
2023-06-30 -$0.34